Anuh Pharma Limited (ANUHPHR.BO)
INR 221.35
(-0.23%)
INR 221.35
(-0.23%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 138.24 Million | 539.01 Million | 288.63 Million | -187.34 Million | 489.3 Million | 71.24 Million |
| Net Income | 600.57 Million | 474.7 Million | 391.22 Million | 385.51 Million | 191.55 Million | 324.01 Million |
| Depreciation & Amortization | 85.83 Million | 97 Million | 119.59 Million | 150.75 Million | 70.32 Million | 16.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -437.25 Million | 157.71 Million | -89.94 Million | -545.28 Million | 268.71 Million | -131.96 Million |
| Other non-cash items | 401.74 Million | -190.4 Million | -132.23 Million | -178.33 Million | -41.29 Million | -137.42 Million |
| Investing Cash Flow | -2.29 Million | -434.83 Million | -78.17 Million | 522.02 Million | -765.29 Million | 28.61 Million |
| Investments in PPE | -50.16 Million | -15.5 Million | -16.14 Million | -61.53 Million | -356.29 Million | -289.27 Million |
| Acquisitions | - | 566 Thousand | 1.43 Million | 1.09 Million | 120 Thousand | 968 Thousand |
| Investment purchases | - | -438.14 Million | -86.58 Million | - | -434.59 Million | - |
| Sales/Maturities of investments | 47.87 Million | - | 23.13 Million | 562.15 Million | - | 290.57 Million |
| Other Investing Activities | 59.34 Million | 18.23 Million | 1000.00 | 20.31 Million | 25.47 Million | 26.35 Million |
| Financing Cash Flow | -83.19 Million | -122.86 Million | -194.49 Million | -331.15 Million | 221.71 Million | -65.12 Million |
| Debt repayment | -20.13 Million | -31.11 Million | -104.86 Million | -309.62 Million | -401.74 Million | -19.41 Million |
| Dividends payments | -100.25 Million | -87.48 Million | -75.57 Million | - | -166.54 Million | -82.97 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.56 Million | -4.27 Million | -14.04 Million | -21.52 Million | 790 Million | 37.27 Million |
| Accounts receivables | -187.47 Million | -353.19 Million | -287.96 Million | -258.24 Million | -64.96 Million | -36.97 Million |
| Accounts payables | -125.87 Million | 311.9 Million | 15.58 Million | 153.77 Million | 457.22 Million | 69.32 Million |
| Inventory | -27.63 Million | 72.87 Million | 15.02 Million | -199.38 Million | -186.36 Million | -109.46 Million |
| Other working capital | -96.26 Million | 126.13 Million | 167.41 Million | -241.42 Million | 62.82 Million | -54.84 Million |
| Cash at beginning of period | 51.51 Million | 37.95 Million | 21.98 Million | 18.45 Million | 72.72 Million | 37.99 Million |
| Cash at end of period | 96.73 Million | 19.26 Million | 37.95 Million | 21.98 Million | 18.45 Million | 72.72 Million |
| Capital Expenditure | -50.16 Million | -15.5 Million | -16.14 Million | -61.53 Million | -356.29 Million | -289.27 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 45.21 Million | -18.69 Million | 15.97 Million | 3.53 Million | -54.27 Million | 34.73 Million |
| Free Cash Flow | 88.07 Million | 523.51 Million | 272.48 Million | -248.88 Million | 133.01 Million | -218.03 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 600.57 Million | 191.13 Million | 138.33 Million | 117.52 Million | 474.7 Million | 96.23 Million |
| Depreciation & Amortization | 85.83 Million | 22.02 Million | 21.45 Million | 20.08 Million | 97 Million | 24.07 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -437.25 Million | - | - | - | 157.71 Million | - |
| Other non-cash items | 401.74 Million | -22.02 Million | -21.45 Million | -20.08 Million | -190.4 Million | -24.07 Million |
| Investing Cash Flow | -2.29 Million | - | - | - | -434.83 Million | - |
| Investments in PPE | -50.16 Million | - | - | - | -15.5 Million | - |
| Acquisitions | - | - | - | - | 566 Thousand | - |
| Investment purchases | - | - | - | - | -438.14 Million | - |
| Sales/Maturities of investments | 47.87 Million | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 18.23 Million | - |
| Financing Cash Flow | -83.19 Million | - | - | - | -122.86 Million | - |
| Debt repayment | -20.13 Million | - | - | - | -31.11 Million | - |
| Dividends payments | -100.25 Million | - | - | - | -87.48 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -4.27 Million | - |
| Accounts receivables | -187.47 Million | - | - | - | -353.19 Million | - |
| Accounts payables | -125.87 Million | - | - | - | 311.9 Million | - |
| Inventory | -27.63 Million | - | - | - | 72.87 Million | - |
| Other working capital | -96.26 Million | - | - | - | 126.13 Million | - |
| Cash at beginning of period | 51.51 Million | 144.87 Million | 6.53 Million | 51.51 Million | 37.95 Million | -44.71 Million |
| Cash at end of period | 96.73 Million | 191.13 Million | 144.87 Million | 117.52 Million | 19.26 Million | 51.51 Million |
| Capital Expenditure | -50.16 Million | - | - | - | -15.5 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 45.21 Million | 46.26 Million | 138.33 Million | 66.01 Million | -18.69 Million | 96.23 Million |
| Free Cash Flow | 88.07 Million | 191.13 Million | 138.33 Million | 117.52 Million | 523.51 Million | 96.23 Million |
CCT
GLOW
TDRRF
NIMU
001515
PAYOW